Read more

February 22, 2022
1 min read
Save

Top in ID: CDC director addresses vaccine hesitancy, US woman achieves HIV remission

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Last week, Healio provided extensive coverage of the virtual Conference on Retroviruses and Opportunistic Infections.

During the opening session, CDC Director Rochelle P. Walensky, MD, MPH, responded to questions regarding the U.S. and global response to COVID-19 and provided insight on how to combat vaccine hesitancy. It was the top story in infectious disease last week.

Source: Adobe Stock.
Source: Adobe Stock

The second top story was about a presentation on the first woman, who was also the first U.S. patient and third person overall, to achieve sustained HIV remission after undergoing a stem cell transplant.

Read these and more top stories in infectious disease below:

‘Listen before you talk’: CDC’s Walensky addresses vaccine hesitancy

Walensky said that COVID-19 vaccine uptake has been poor and provided some advice for combating vaccine hesitancy in the United States. Read more.

US woman is third person to achieve sustained HIV remission after stem cell transplant

A middle-aged woman from the United States is the third person — and first woman — to achieve sustained treatment-free HIV remission after undergoing a stem cell transplant, researchers announced Tuesday. Read more.

Lifetime risk for HIV decreases among men and women in US

The overall lifetime risk for an HIV diagnosis in the United States has decreased, CDC researchers found, although decreases were not experienced by all races or ethnicities. Read more.

Study suggests young women prefer vaginal ring over oral PrEP for HIV prevention

Adolescent girls and young women preferred the dapivirine ring over oral PrEP for HIV prevention by a two to one margin in a study conducted in three African countries, researchers reported Tuesday. Read more.

After more than 40 years, ‘HIV vaccine remains elusive’

After more than 40 years, a vaccine against HIV “remains elusive” because of several significant barriers, including the complexity of the virus and shifts in focus to other infectious diseases, like COVID-19, an expert said. Read more.